AMG 133 Shows Promise in Obesity Treatment with Dual Action on GIPR and GLP-1 Receptors Obesity is a heterogeneous chronic disease that has become an extremely prevalent public health problem and one of the greatest threats to human health and well-being in the 21st century. Obesity-related complications place an enormous burden on patients and healthcare systems worldwide, and there is an urgent need for effective and safe obesity treatments.
Enteric insulin-based drugs...
0 Μοιράστηκε
517 Views
0 Προεπισκόπηση